Institute for Clinical and Economic Review

Institution (Nonprofit)

Homepage Wikipedia ROR

Also Known As

Institute for Clinical and Economic Review · Acronym: ICER

487

Publications

21.8K

Citations

Authors

330

Concepts

About

Institute for Clinical and Economic Review is a nonprofit institution in Boston, United States known for medicine, public health, and health policy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Business	11	15	586
2	Health Sciences	6	16	257
3	Engineering	5	10	360
4	Education	4	4	160
5	Arts	2	2	50

Institute for Clinical and Economic Review

487

Publications

21.8K

Citations

Page 1

	Year	Citations
The GRADE Working Group clarifies the construct of certainty of evidence Monica Hultcrantz, David M. Rind, Elie A. Akl, Journal of Clinical Epidemiology	2017	737
Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults Michael D. Kappelman, Sheryl L. Rifas‐Shiman, Carol Q. Porter, Gastroenterology Primary CareHealth EconomicsHealth PolicyHealth Care ReimbursementUs Children	2008	633
Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease Dhruv S. Kazi, Andrew E. Moran, Pamela G. Coxson, JAMA	2016	364
United States Valuation of EQ-5D-5L Health States Using an International Protocol A. Simon Pickard, Ernest H. Law, Ruixuan Jiang, Value in Health	2019	360
Revascularization of Human Acellular Dermis in Full-Thickness Abdominal Wall Reconstruction in the Rabbit Model Nathan G. Menon, Eduardo D. Rodriguez, Colman K. Byrnes, Annals of Plastic Surgery	2003	240
Why Observational Studies Should Be Among The Tools Used In Comparative Effectiveness Research Nancy A Dreyer, Sean Tunis, Marc L. Berger, Health Affairs Evidence-based MedicineResearch EvaluationResearch EthicsEffectiveness ResearchMethodology Comparison	2010	203
Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial Dhruv S. Kazi, Joanne Penko, Pamela G. Coxson, JAMA Cost-effectiveness AnalysisPharmacotherapyPreventive CardiologyUnited StatesCoronary Artery Disease	2017	144
Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population Harinder Singh Chahal, Elliot Marseille, Jeffrey A. Tice, JAMA Internal Medicine	2015	137
Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease Michael D. Kappelman, Carol Q. Porter, Joseph A. Galanko, Inflammatory Bowel Diseases	2010	121
Observation Versus Initial Treatment for Men With Localized, Low-Risk Prostate Cancer Julia H. Hayes, Daniel A. Ollendorf, Steven D. Pearson, Annals of Internal Medicine	2013	116

Page 1